These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 18227956)
1. The effects of intravesical pentosanpolysulfate treatment on the symptoms of patients with bladder pain syndrome/interstitial cystitis: preliminary results. Daha LK; Lazar D; Simak R; Pflüger H Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jul; 19(7):987-90. PubMed ID: 18227956 [TBL] [Abstract][Full Text] [Related]
2. Safety and dose flexibility clinical evaluation of intravesical liposome in patients with interstitial cystitis or painful bladder syndrome. Lee WC; Chuang YC; Lee WC; Chiang PH Kaohsiung J Med Sci; 2011 Oct; 27(10):437-40. PubMed ID: 21943815 [TBL] [Abstract][Full Text] [Related]
3. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome. Chuang YC; Lee WC; Lee WC; Chiang PH J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. Davis EL; El Khoudary SR; Talbott EO; Davis J; Regan LJ J Urol; 2008 Jan; 179(1):177-85. PubMed ID: 18001798 [TBL] [Abstract][Full Text] [Related]
6. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome. Chuang YC; Kuo HC J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome. Lim YN; Dwyer P; Murray C; Karmakar D; Rosamilia A; Thomas E Int Urogynecol J; 2017 Jul; 28(7):1085-1089. PubMed ID: 27987022 [TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. Bade JJ; Laseur M; Nieuwenburg A; van der Weele LT; Mensink HJ Br J Urol; 1997 Feb; 79(2):168-71. PubMed ID: 9052464 [TBL] [Abstract][Full Text] [Related]
9. Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral Stents Following Endourological Interventions. Raisin G; Dothan D; Perez D; Ala-Adin N; Kafka I; Shenfeld O; Hatumi S; Malchi N; Gordon A; Touitou D; Moldwin R; Nassar T; Chertin B Urology; 2023 Aug; 178():42-47. PubMed ID: 37268171 [TBL] [Abstract][Full Text] [Related]
10. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome. Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413 [TBL] [Abstract][Full Text] [Related]
11. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution. Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of intravesical ozone in interstitial cystitis by the O'Leary-Sant symptom index. Pires MV; de Lima CJ; Carvalho HC; Moreira LH; Fernandes AB Int Urogynecol J; 2023 Jul; 34(7):1437-1446. PubMed ID: 36242631 [TBL] [Abstract][Full Text] [Related]
13. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis. Lee CL; Kuo HC Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677 [TBL] [Abstract][Full Text] [Related]
14. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment. Liang CC; Lin YH; Hsieh WC; Huang L Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165 [TBL] [Abstract][Full Text] [Related]
15. Liposomal bladder instillations for IC/BPS: an open-label clinical evaluation. Peters KM; Hasenau D; Killinger KA; Chancellor MB; Anthony M; Kaufman J Int Urol Nephrol; 2014 Dec; 46(12):2291-5. PubMed ID: 25209396 [TBL] [Abstract][Full Text] [Related]
16. Association between response to pentosan polysulfate sodium therapy for interstitial cystitis and patient questionnaire-based treatment satisfaction. Sand PK; Kaufman DM; Evans RJ; Zhang HF; Alan Fisher DL; Nickel JC Curr Med Res Opin; 2008 Aug; 24(8):2259-64. PubMed ID: 18582395 [TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis. Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of intravesical instillation with fulguration-hydrodistention on female interstitial cystitis]. Xin P; Zhang H; Jiang ZM Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):865-870. PubMed ID: 37807741 [TBL] [Abstract][Full Text] [Related]
19. Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study. Rappaport YH; Zisman A; Jeshurun-Gutshtat M; Gerassi T; Hakim G; Vinshtok Y; Stav K Urology; 2018 Apr; 114():60-65. PubMed ID: 29307733 [TBL] [Abstract][Full Text] [Related]
20. On- and post-treatment symptom relief by repeated instillations of heparin and alkalized lidocaine in interstitial cystitis. Nomiya A; Naruse T; Niimi A; Nishimatsu H; Kume H; Igawa Y; Homma Y Int J Urol; 2013 Nov; 20(11):1118-22. PubMed ID: 23432185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]